Previous close | 31.50 |
Open | 31.50 |
Bid | 22.20 |
Ask | 24.20 |
Strike | 75.00 |
Expiry date | 2026-01-16 |
Day's range | 31.50 - 31.50 |
Contract range | N/A |
Volume | |
Open interest | 73 |
NYON, Switzerland, May 08, 2024--Edwards Lifesciences today announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the only transcatheter aortic heart valve to incorporate the company’s breakthrough RESILIA tissue technology, designed to extend the valve’s durability.*
Toda's Research Daily features new research reports on 16 major stocks, including Salesforce, Inc. (CRM), BP p.l.c. (BP) and The Southern Company (SO).
ALC vs. EW: Which Stock Is the Better Value Option?